Navigation Links
Jazz Pharmaceuticals to Hold Investor Conference Call on January 5 to Discuss 2012 Financial Guidance and Azur Pharma Transaction

PALO ALTO, Calif., Jan. 4, 2012 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced two upcoming investor events:

  • The company will hold a conference call on January 5, 2012 at 1:30 p.m. Pacific Time/4:30 p.m. Eastern Time to discuss high-level 2012 financial guidance and the anticipated timing of the closing for the business combination with Azur Pharma, and to provide an update on growth of Xyrem® (sodium oxybate).  A live webcast of the conference call may be accessed from the Investors section of the Jazz Pharmaceuticals website at  Investors may participate in the conference call by dialing 866-825-1692 in the U.S., or 617-213-8059 outside the U.S., and entering passcode 88638936.                        
  • In addition, Bruce Cozadd, the company's chairman and chief executive officer, will provide a business update at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 11, 2012 at 10:30 a.m. Pacific Time/1:30 p.m. Eastern Time. A live webcast of the J.P. Morgan presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at


To access the live webcast for these events, please connect to the Jazz Pharmaceuticals website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary.  An archived version of both webcasts will be available for at least one week on the Investors section of the company's website at

About Jazz Pharmaceuticals

Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty biopharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs. For further information, see



SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Radient Pharmaceuticals Announces Reverse Stock Split
2. Idenix Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
3. Optimer Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
4. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
5. Endo Pharmaceuticals to Present at J.P. Morgan 30th Annual Healthcare Conference
6. Provenance Biopharmaceuticals Corp. Announces $8M Financing Arrangement
7. Valeant Pharmaceuticals Completes Acquisition of iNova
8. Inspiration Biopharmaceuticals Expands Leadership Team with Four New Hires
9. Valeant Pharmaceuticals to Hold Conference Call to Announce 2012 Financial Guidance
10. Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million
11. Radient Pharmaceuticals Corporation Expands Distribution of Onko-Sure® in Asia; Receives Payment on First Order of 60 Kits
Post Your Comments:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):